Retatrutide is a newly discovered compound that shows promise as a treatment for type 2 diabetes. It functions as a stimulator of the glucagon-like peptide-1 (GLP-1) receptor, which plays a crucial role in regulating https://cyrusidzn666556.blogs-service.com/70080693/semaglutide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes